Nanotechnology in the COVID-19 Pandemic

Nanotechnology has shown great potential in contributing to the efficient regulation and management of COVID-19. By designing materials with precise structures and molecular architectures, nanoscience enables the development of particles ranging from one nanometer to hundreds of nanometers in size. These nanomaterials exhibit unique optical, electrical, and biological properties due to their nanoscale structure. Given the similar scale of activity between nanoparticles and viruses, nanotechnology offers promising applications in vaccine development and immune system modulation. Researchers in nanomedicine have long studied the ability of various nanosystems and viral vectors to deliver genes, which has informed approaches to combatting high infectivity rates in viruses like SARS-CoV-2.

 

Key applications of nanotechnology in COVID-19 include:

  • Nanotechnology-based vaccines
  • Immunization through delivery of viral biomolecules
  • Nucleic acid-based nanovaccines

    Related Conference of Nanotechnology in the COVID-19 Pandemic

    December 02-03, 2024

    10th Annual Meet on Nanoscience and Nanotechnology

    Prague, Czech Republic
    March 17-18, 2025

    8th International Conference on Nanomedicine and Nanotechnology

    Singapore City, Singapore
    April 14-15, 2025

    37th Nano Congress for Future Advancements

    Aix-en-Provence, France
    June 16-17, 2025

    42nd Global Nanotechnology Congress

    Amsterdam, Netherlands
    June 24-25, 2025

    28th World Nanotechnology Congress

    Paris, France
    October 21-22, 2025

    42nd Global Summit on Nanoscience and Technology

    London, UK

    Nanotechnology in the COVID-19 Pandemic Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in